To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Aquamid® is the trade name for a specific formulation of hydrophilic polyacrylamide gel. Available as an injectable implant, it is manufactured by the Danish company Ferrosan and is used as a subdermal filler for aesthetic purposes.
Additional recommended knowledge
It is comprised of 97.5% apyrogenic water bound to 2.5% cross-linked acrylamide polymer.
Most commonly, it is injected under wrinkles and aging lines of the face such as the nasolabial folds, and forehead wrinkles. It may also be used for filling aging-related facial hollows, under and around the eyes. It is also used for lip augmentation.
The effects of Aquamid are currently known to last at least 11 years as the product has not been field-trialled longer than this period yet. It is currently not approved by the FDA for use in the United States but clinical trials were announced to be underway in August 2006.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Aquamid". A list of authors is available in Wikipedia.|